Phenotypic and Molecular Characterisations of Carbapenem-resistant Acinetobacter baumannii Isolates Collected within the EURECA Study.

[1]  B. Lukovic,et al.  The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates , 2020, Antimicrobial Resistance & Infection Control.

[2]  I. Gyssens,et al.  Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia. , 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[3]  I. Mitov,et al.  Clonal spread of carbapenem-resistant Acinetobacter baumannii isolates among Bulgarian critically ill patients undergoing renal replacement therapy (2016–2018) , 2020, Infectious diseases.

[4]  Herman Goossens,et al.  BacPipe: A Rapid, User-Friendly Whole-Genome Sequencing Pipeline for Clinical Diagnostic Bacteriology , 2019, iScience.

[5]  K. Holt,et al.  Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive , 2019, bioRxiv.

[6]  Evangelos I. Kritsotakis,et al.  Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options. , 2019, The Journal of antimicrobial chemotherapy.

[7]  I. Sirakov,et al.  Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016). , 2019, Journal of global antimicrobial resistance.

[8]  H. Goossens,et al.  Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey. , 2019, International journal of antimicrobial agents.

[9]  Wenguang Xiong,et al.  Draft genome sequence of an OXA-23, OXA-66, ADC-25 and TEM-1D co-producing Acinetobacter baumannii ST195 isolated from a patient with neonatal pneumonia in China. , 2019, Journal of global antimicrobial resistance.

[10]  Alexandre P. Francisco,et al.  GrapeTree: visualization of core genomic relationships among 100,000 bacterial pathogens , 2017, bioRxiv.

[11]  Mirko Rossi,et al.  chewBBACA: A complete suite for gene-by-gene schema creation and strain identification , 2017, bioRxiv.

[12]  E. Roilides,et al.  Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015). , 2017, Future microbiology.

[13]  Dag Harmsen,et al.  Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii , 2017, PloS one.

[14]  H. Goossens,et al.  EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study , 2017, BMJ Open.

[15]  G. Werner,et al.  Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital. , 2017, Microbial drug resistance.

[16]  A. Tsakris,et al.  First report of an NDM-1 metallo-β-lactamase-producing Acinetobacter baumannii clinical isolate in Greece. , 2016, International journal of antimicrobial agents.

[17]  T. Naas,et al.  First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia , 2016, Antimicrobial Agents and Chemotherapy.

[18]  H. Goossens,et al.  The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance. , 2016, The Journal of antimicrobial chemotherapy.

[19]  S. Wai,et al.  Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates , 2016, Antimicrobial Agents and Chemotherapy.

[20]  J. Begović,et al.  Carbapenem-Resistant Acinetobacter baumannii from Serbia: Revision of CarO Classification , 2015, PloS one.

[21]  P. Nordmann,et al.  GES-type and OXA-23 carbapenemase-producing Acinetobacter baumannii in Turkey. , 2014, The Journal of antimicrobial chemotherapy.

[22]  P. Nordmann,et al.  Association of the Emerging Carbapenemase NDM-1 with a Bleomycin Resistance Protein in Enterobacteriaceae and Acinetobacter baumannii , 2012, Antimicrobial Agents and Chemotherapy.

[23]  S. Pournaras,et al.  Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). , 2011, The Journal of antimicrobial chemotherapy.

[24]  P. Nordmann,et al.  Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  S. Brisse,et al.  Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  P. Krishnan,et al.  Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. , 2010, The Journal of antimicrobial chemotherapy.

[27]  S. Amyes,et al.  Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes , 2010, Journal of Clinical Microbiology.

[28]  P. Higgins,et al.  Global spread of carbapenem-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.

[29]  S. Amyes,et al.  OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  R. Bonomo,et al.  Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  R. Weinstein,et al.  Acinetobacter infection. , 2008, The New England journal of medicine.